Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to -$9.0 million.

  • Guardian Pharmacy Services' Cash from Investing Activities fell 2662.05% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.1 million, marking a year-over-year decrease of 3693.94%. This contributed to the annual value of -$30.4 million for FY2024, which is 12622.57% down from last year.
  • As of Q3 2025, Guardian Pharmacy Services' Cash from Investing Activities stood at -$9.0 million, which was down 2662.05% from -$13.0 million recorded in Q2 2025.
  • In the past 5 years, Guardian Pharmacy Services' Cash from Investing Activities ranged from a high of -$1.1 million in Q4 2023 and a low of -$13.1 million during Q2 2024
  • Moreover, its 3-year median value for Cash from Investing Activities was -$6.9 million (2024), whereas its average is -$7.4 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 47750.65% in 2024, then soared by 76.31% in 2025.
  • Quarter analysis of 3 years shows Guardian Pharmacy Services' Cash from Investing Activities stood at -$1.1 million in 2023, then tumbled by 477.51% to -$6.6 million in 2024, then plummeted by 35.36% to -$9.0 million in 2025.
  • Its last three reported values are -$9.0 million in Q3 2025, -$13.0 million for Q2 2025, and -$5.5 million during Q1 2025.